Skip to main content
Contact Us
Subscribe
E-Edition
63°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
S&P Biotech Bull 3X Direxion
(NY:
LABU
)
125.25
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,312
Open
125.25
Bid (Size)
123.00 (1)
Ask (Size)
123.52 (1)
Prev. Close
125.25
Today's Range
125.25 - 125.25
52wk Range
2.420 - 176.99
Shares Outstanding
73,744
Dividend Yield
0.00%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Can These 5 Assets Skyrocket Your Portfolio?
September 22, 2024
Are Verizon, Amazon, Cisco, Amgen, and the S&P Biotech Bull 3X Shares ETF poised to make your portfolio skyrocket? In this video, I take a closer look.
Via
Talk Markets
Topics
ETFs
Stocks
Exposures
US Equities
EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks
August 30, 2024
Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment.
Via
Benzinga
Performance
YTD
-0.39%
-0.39%
1 Month
-3.56%
-3.56%
3 Month
+15.44%
+15.44%
6 Month
+8.86%
+8.86%
1 Year
+3540.99%
+3540.99%
More News
Read More
Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win
June 06, 2024
Via
Talk Markets
Topics
ETFs
Stocks
Exposures
US Equities
The 3 Best Leveraged ETFs for April 2024
April 02, 2024
Via
InvestorPlace
Topics
ETFs
Sector Rotation
January 08, 2022
Via
Talk Markets
5 Best-Performing Leveraged ETFs Of February
March 02, 2024
Via
Talk Markets
Topics
ETFs
Stocks
Exposures
US Equities
Stocks To Watch This Week - Sunday, Feb. 11
February 11, 2024
Via
Talk Markets
Topics
ETFs
Want Diversified Upside in Biotechnology? Check out LABU
March 22, 2023
Via
MarketBeat
Topics
ETFs
Stocks
Exposures
US Equities
The Week Ahead Commentary - Saturday, Feb. 4
February 05, 2023
Via
Talk Markets
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
January 17, 2023
Via
Talk Markets
3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty
February 22, 2022
Via
InvestorPlace
The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)…
February 11, 2022
Via
Talk Markets
3 Biotech Stocks to Buy That Are Under Severe Pressure
January 13, 2022
Via
InvestorPlace
5 Best Leveraged ETFs of Last Week
December 28, 2021
Via
Talk Markets
5 Best-Performing Leveraged ETFs of August
September 01, 2021
Via
Talk Markets
The Week In Charts: Figure This Out And You’ll Own The World
August 07, 2021
Via
Talk Markets
The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs
July 31, 2021
Via
Talk Markets
The Week In Charts: Trading Stuff Part 2-IPOs, ETFs, And, The Secret To Trading
July 23, 2021
Via
Talk Markets
These Were The Stocks David Green Discussed On His Show This Morning
July 06, 2021
Via
Benzinga
The Week In Charts-Volatility: Rabbit Hole Or Holy Grail?
June 11, 2021
Via
Talk Markets
A Biotech ETF For Aggressive, Risk-Tolerant Investors
June 08, 2021
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
A Biotech ETF For Aggressive, Risk-Tolerant Investors
June 08, 2021
Via
Benzinga
Exposures
Product Safety
CrowdStrike Stock Earnings Trade
June 06, 2021
Via
Talk Markets
This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming
May 05, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.